Mimedx Group Inc [MDXG] stock prices are up 18.67% to $7.31 at the moment. An important factor to consider is whether the stock is rising or falling in short-term value. The MDXG shares have gain 13.69% over the last week, with a monthly amount glided 6.25%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Mimedx Group Inc [NASDAQ: MDXG] stock has seen the most recent analyst activity on March 07, 2024, when Lake Street initiated its Buy rating and assigned the stock a price target of $12. Previously, Craig Hallum started tracking the stock with Buy rating on October 27, 2023, and set its price target to $12. On October 13, 2022, Mizuho initiated with a Buy rating and assigned a price target of $7 on the stock. Northland Capital started tracking the stock assigning a Outperform rating and suggested a price target of $23 on July 26, 2021. H.C. Wainwright initiated its recommendation with a Buy and recommended $20 as its price target on March 19, 2021.
The stock price of Mimedx Group Inc [MDXG] has been fluctuating between $3.79 and $9.27 over the past year. Currently, Wall Street analysts expect the stock to reach $10 within the next 12 months. Mimedx Group Inc [NASDAQ: MDXG] shares were valued at $7.31 at the most recent close of the market. An investor can expect a potential return of 36.8% based on the average MDXG price forecast.
Analyzing the MDXG fundamentals
The Mimedx Group Inc [NASDAQ:MDXG] reported sales of 321.48M for trailing twelve months, representing a surge of 16.75%. Gross Profit Margin for this corporation currently stands at 0.83% with Operating Profit Margin at 0.16%, Pretax Profit Margin comes in at 0.14%, and Net Profit Margin reading is 0.24%. To continue investigating profitability, this company’s Return on Assets is posted at 0.36, Equity is 1.11 and Total Capital is 0.3. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.12.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 6.63 points at the first support level, and at 5.94 for the second support level. However, for the 1st resistance point, the stock is sitting at 7.70, and for the 2nd resistance point, it is at 8.08.
Mimedx Group Inc [MDXG] reported earnings per share of $0.32 for its fiscal quarter that ended on 12/31/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of $0.07/share, meaning a difference of $0.25 and a surprise factor of 357.10%. By comparison, the stated earnings for the previous quarter ended on 9/30/2023 were $0.06 per share as compared to estimates of $0.04 per share, a difference of $0.02 representing a surprise of 50.00%.
Ratios To Look Out For
It’s worth pointing out that Mimedx Group Inc [NASDAQ:MDXG]’s Current Ratio is 3.57. On the other hand, the Quick Ratio is 3.11, and the Cash Ratio is 1.15. Considering the valuation of this stock, the price to sales ratio is 3.36, the price to book ratio is 7.49 and price to earnings (TTM) ratio is 21.23.
Transactions by insiders
Recent insider trading involved Hulse William Frank IV, General Counsel and CAO, that happened on Mar 13 ’24 when 20381.0 shares were sold. Chief Operating Officer, Whitlow Ricci S completed a deal on Feb 20 ’24 to sell 15271.0 shares. Meanwhile, Chief Operating Officer Whitlow Ricci S sold 15493.0 shares on Feb 16 ’24.
